Protective effect of whey proteins against nonalcoholic fatty liver in rats

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Hamad, Essam M ^a   Taha, Soad H ^a   Abou Dawood, Abdel Gawad I ^a   Sitohy, Mahmoud Z ^b   Abdel Hamid, Mahmoud ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA LACTALBUMIN; ASPARTATE AMINOTRANSFERASE; BETA LACTOGLOBULIN; GLUCOSE; GLUTATHIONE; GLYCOPROTEIN; MALONALDEHYDE; MILK PROTEIN; TRIACYLGLYCEROL; CHOLESTEROL; WHEY PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEEDING; GLUCOSE BLOOD LEVEL; GROWTH CURVE; LIPID PEROXIDATION; LIVER BIOPSY; LIVER CELL; LIVER PROTECTION; LIVER WEIGHT; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; RAT; WEIGHT REDUCTION; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECT; FATTY LIVER; LIVER; LOW FAT DIET; METABOLISM; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PATHOLOGY; WISTAR RAT;

RATTUS;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIET, FAT-RESTRICTED; FATTY LIVER; LIPID PEROXIDATION; LIVER; MALE; MILK PROTEINS; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 79953862878     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-57     Document Type: Article

References (25)

1. Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. Y Qin Y Tian, Lipids in health and disease 2010 9 78 10.1186/1476-511X-9-78 20653983
2. Trends in the prevalence of overweight among women in Egypt. P Nahmias, PAA conference New Orleans, USA 2008
3. Obesity, insulin resistance and other clinicopathological correlate of pediatric nonalcoholic fatty liver disease. JB Schwimmer R Deutsch JB Rouch C Behling R Newbury JJ Lavine, J Pediatr 2003 143 500 505 (2003) 10.1067/S0022-3476(03)00325-1 14571229 (Pubitemid 37352510)
4. Whey proteins influence hepatic glutathione after CCl4 intoxication. E Balbis S Patriarca A Furfaro S Millanta GS Sukkar MU Marinari AM Pronzato D Cottalasso N Traverso, Toxicology and Industrial Health 2009 25 325 328 10.1177/0748233709104870 19651804
5. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. P Micke KM Beeh JF Schlaak R Buhl, Eur J Clin Invest 2001 31 171 8 10.1046/j.1365-2362.2001.00781.x 11168457 (Pubitemid 32199911)
6. Hepatoprotective and antioxidant action of whey protein and its fractions in rats after acute CCl4 exposure. SH Taha AM Abd El-Fattah AA El-Nimr SA Nada JM Kassem, J Agric Sci Mansoura Univ 2007 32 533 541
7. Health-promoting effects of bovine colostrum in Type 2 diabetic patients can reduce blood glucose, cholesterol, triglyceride and ketones. HJ Kim SW Jung N Choi D Kim D Shin JY Kim, The Journal of Nutritional Biochemistry 2009 20 298 303 10.1016/j.jnutbio.2008.04.002 18602824
8. Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction. TK Pilvi T Seppanen-Laakso H Simolin P Finckenberg A Huotari KH Herzig R Korpela M Oresic EM Mervaala, World J Gastroenterology 2008 14 4462 72 10.3748/wjg.14.4462
9. Open-labeled pilot study of cysteine-rich whey protein isolate supplementation for nonalcoholic steatohepatitis patients. T Chitapanarux P Tienboon P Suwalee L Donrawee, Journal of Gastroenterology and Hepatology 2009 24 1045 1050 10.1111/j.1440-1746.2009.05865.x 19638084
10. Treatment of non-alcoholic fatty liver disease. LA Adams P Angulo, Postgrad Med J 2006 82 315 322 10.1136/pgmj.2005.042200 16679470 (Pubitemid 43780662)
11. Anovel therapeutic drug (copper nicotinic acid complex) for non-alcoholic fatty liver. RH Salama AY Nassar AA Nafady HH Mohamed, Liver international 2007 27 454 464 10.1111/j.1478-3231.2007.01460.x 17403185 (Pubitemid 46534567)
12. A whey protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study. JL Frestedt JL Zenk MA Kuskowski LS Ward ED Bastian, Nutr Metab 2008 5 8 10.1186/1743-7075-5-8 (Pubitemid 351520310)
13. Dairy protein attenuates weight gain in obese rats better than whey or casein alone. LK Eller RA Reimer, Obesity 2010 18 704 11 10.1038/oby.2009.300 19779477
14. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. WG Thompson HN Rostad DJ Janzow JM Slezak KL Morris MB Zemel, Obesity Research 2005 13 1344 53 10.1038/oby.2005.163 16129716
15. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. S Parekh FA Anania, Gastroenterology 2007 132 2191 207 10.1053/j.gastro.2007.03.055 17498512 (Pubitemid 46693752)
16. Nonalcoholic fatty liver disease in severely obese subjects. PM Gholam L Flancbaum JT Machan DA Charney DP Kotle, Am J Gastroenterology 2007 102 399 408 10.1111/j.1572-0241.2006.01041.x (Pubitemid 46160554)
17. Resveratrol inhibits nonalcoholic fatty liver disease in rats. L Bujanda H Elizabeth L Mikel B Marta A Pablo G Nerea S Cristina C Angel I Belen G Alberto A Juan, BMC Gastroenterology 2008 8 40 10.1186/1471-230X-8-40 18782455
18. Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease. T Shigesawa C Sato F Marumo, J Gastroenterology Hepatology 1992 7 7 11 10.1111/j.1440-1746.1992.tb00926.x
19. Lipid peroxidation-DNA damage by malondialdehyde. LJ Marnett, Mutation Research 1999 424 83 95 10064852
20. Dietary cysteine alleviates sucrose-induced oxidative stress and insulin resistance. C Blouet F Mariotti D Azzout-Marniche V Mathé T Mikogami D Tomé J Huneau, Free Radical Biology & Medicine 2007 42 1089 1097 (Pubitemid 46371367)
21. Whey from cultured skim milk decreases serum cholesterol and increases antioxidant enzymes in liver and red blood cells in rats. M Zommara N Tachibana M Sakono Y Suzuki T Oda H Hashiba K Imaizumi, Nutrition Research 1996 16 293 302 10.1016/0271-5317(96)00013-9 (Pubitemid 26066187)
22. Dietary supplementation with pressurized whey in patients with cystic fibrosis. LC Lands M Iskandar N Beaudoin B Meehan N Dauletbaev Y Berthiuame, J Med Food 2010 13 77 82 10.1089/jmf.2008.0326 20136439
23. Therapeutic applications of whey protein. K Marshall, Alternative Medicine Review 2004 2 136 156 (Pubitemid 38821803)
24. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. EM Brunt CG Janney AM Di Bisceglie BA Neuschwander-Tetri BR Bacon, Am J Gastroenterol 1999 94 2467 2474 10.1111/j.1572-0241.1999.01377.x 10484010 (Pubitemid 29420675)
25. SPSS for Windows. SPSS, Chicago: SPSS Inc 2007 Release 16.0.0